In contrast, TGF-β1, which is present in higher levels in the systemic environment, promotes oligodendrocyte maturation, while lower levels in circulating TGF-β prevent remyelination in the spinal cord after toxin-induced demyelination [192]. The gene discussed is TGFB1; the disease is Peripheral demyelination.